Primecap Management CO Alkermes Plc. Transaction History

Primecap Management CO

$134 Billion
Q3 2024

A detailed history of Primecap Management CO transactions in Alkermes Plc. stock. As of the latest transaction made, Primecap Management CO holds 3,297,115 shares of ALKS stock, worth $97.8 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

3,297,115

Previous 3,385,795 2.62%

Holding current value

$97.8 Million

Previous $81.6 Million 13.1%

% of portfolio

0.07%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$23.01 - $28.55 $2.04 Million - $2.53 Million	-88,680 Reduced 2.62%	3,297,115 $92.3 Million
Q2 2024 Aug 09, 2024	SELL	$23.21 - $27.24 $2.03 Million - $2.38 Million	-87,395 Reduced 2.52%	3,385,795 $81.6 Million
Q1 2024 May 13, 2024	SELL	$26.4 - $32.56 $2.44 Million - $3.01 Million	-92,435 Reduced 2.59%	3,473,190 $94 Million
Q4 2023 Feb 09, 2024	SELL	$23.37 - $28.68 $7.4 Million - $9.08 Million	-316,605 Reduced 8.16%	3,565,625 $98.9 Million
Q3 2023 Nov 13, 2023	SELL	$27.17 - $31.97 $6.63 Million - $7.8 Million	-244,010 Reduced 5.91%	3,882,230 $109 Million
Q2 2023 Aug 11, 2023	SELL	$28.34 - $33.63 $2.04 Million - $2.42 Million	-72,050 Reduced 1.72%	4,126,240 $129 Million
Q1 2023 May 15, 2023	SELL	$25.31 - $29.02 $15.3 Million - $17.6 Million	-605,040 Reduced 12.6%	4,198,290 $118 Million
Q4 2022 Feb 13, 2023	SELL	$21.94 - $26.24 $11.9 Million - $14.3 Million	-544,420 Reduced 10.18%	4,803,330 $126 Million
Q3 2022 Nov 14, 2022	SELL	$22.0 - $31.87 $890,450 - $1.29 Million	-40,475 Reduced 0.75%	5,347,750 $119 Million
Q2 2022 Aug 11, 2022	SELL	$26.4 - $30.54 $7.38 Million - $8.54 Million	-279,665 Reduced 4.93%	5,388,225 $161 Million
Q1 2022 May 11, 2022	SELL	$23.07 - $27.99 $9.4 Million - $11.4 Million	-407,290 Reduced 6.7%	5,667,890 $149 Million
Q4 2021 Feb 11, 2022	SELL	$21.47 - $32.08 $7.18 Million - $10.7 Million	-334,490 Reduced 5.22%	6,075,180 $141 Million
Q3 2021 Nov 12, 2021	SELL	$23.37 - $32.13 $3.48 Million - $4.78 Million	-148,750 Reduced 2.27%	6,409,670 $198 Million
Q2 2021 Aug 10, 2021	SELL	$18.78 - $25.15 $2.1 Million - $2.82 Million	-112,070 Reduced 1.68%	6,558,420 $161 Million
Q1 2021 May 14, 2021	SELL	$18.21 - $23.2 $8.29 Million - $10.6 Million	-455,270 Reduced 6.39%	6,670,490 $125 Million
Q4 2020 Feb 08, 2021	SELL	$15.39 - $22.1 $3.81 Million - $5.47 Million	-247,700 Reduced 3.36%	7,125,760 $142 Million
Q3 2020 Nov 13, 2020	SELL	$16.16 - $20.66 $15.3 Million - $19.5 Million	-944,560 Reduced 11.36%	7,373,460 $122 Million
Q2 2020 Aug 13, 2020	SELL	$13.31 - $19.41 $9.08 Million - $13.2 Million	-681,963 Reduced 7.58%	8,318,020 $161 Million
Q1 2020 May 14, 2020	SELL	$13.06 - $21.24 $66.6 Million - $108 Million	-5,100,193 Reduced 36.17%	8,999,983 $130 Million
Q4 2019 Feb 14, 2020	SELL	$17.29 - $21.74 $135 Million - $170 Million	-7,813,177 Reduced 35.65%	14,100,176 $288 Million
Q3 2019 Nov 13, 2019	SELL	$19.51 - $24.28 $26.2 Million - $32.6 Million	-1,342,387 Reduced 5.77%	21,913,353 $428 Million
Q2 2019 Aug 14, 2019	SELL	$21.47 - $37.33 $167,251 - $290,800	-7,790 Reduced 0.03%	23,255,740 $524 Million
Q1 2019 May 14, 2019	SELL	$28.4 - $36.49 $488,480 - $627,628	-17,200 Reduced 0.07%	23,263,530 $849 Million
Q4 2018 Feb 12, 2019	BUY	$27.94 - $44.61 $214,355 - $342,247	7,672 Added 0.03%	23,280,730 $687 Million
Q3 2018 Nov 13, 2018	SELL	$38.6 - $46.12 $2.45 Million - $2.93 Million	-63,435 Reduced 0.27%	23,273,058 $988 Million
Q2 2018 Aug 13, 2018	BUY	$40.56 - $51.36 $1.79 Million - $2.27 Million	44,160 Added 0.19%	23,336,493 $961 Million
Q1 2018 May 14, 2018	BUY	$53.61 - $67.26 $76.1 Million - $95.5 Million	1,419,402 Added 6.49%	23,292,333 $1.35 Billion
Q4 2017 Feb 13, 2018	BUY	$47.69 - $55.39 $418 Million - $485 Million	8,763,036 Added 66.84%	21,872,931 $1.2 Billion
Q3 2017 Nov 13, 2017	BUY	$49.16 - $54.45 $644 Million - $714 Million	13,109,895	13,109,895 $667 Million

Others Institutions Holding ALKS

# of Institutions

362

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.87B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.

Account

Primecap Management CO Alkermes Plc. Transaction History